Month: July 2021

SAN CARLOS, Calif., July 02, 2021 (GLOBE NEWSWIRE) — Check Point® Software Technologies Ltd. (NASDAQ: CHKP), a leading provider of cyber security solutions globally, today announced that it will release its second quarter financial results for the quarter ended June 30, 2021, on Monday, July 26, 2021, before the U.S. financial markets open. Management will host a video conference call with the investment community at 8:30 AM EDT/5:30 AM PDT on July 26. A live video webcast of the call will be hosted on the company’s website at http://www.checkpoint.com/ir. To follow this and other Check Point news visit:Check Point Blog: http://blog.checkpoint.com/ Twitter: http://www.twitter.com/checkpointsw Facebook: http://www.facebook.com/checkpointsoftware YouTube: http://www.youtube.com/user/CPGlobal LinkedIn: https://www.linkedin.com/company/check-point-software-technologiesAbout...

Roche will present the final analysis from the phase IIIb STASEY study, reinforcing the safety and efficacy profile of Hemlibra in a broad range of people with haemophilia A with factor VIII inhibitors1 Spark Therapeutics will share updated data from the ongoing phase I/II clinical trial of investigational gene therapy SPK-8011, demonstrating that hepatocyte expression of factor VIII can be stable and durable up to four years following vector administration, with an acceptable safety profile2 These data reinforce Roche’s continued focus on advancing care for people living with haemophilia A and provide additional insights into the long-term efficacy and safety profile of Hemlibra, building on the results previously observed in the phase III HAVEN studiesBasel, 02 July 2021 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced...

LEXINGTON, Mass. and AMSTERDAM, The Netherlands, July 02, 2021 (GLOBE NEWSWIRE) — uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced that eight data presentations, of which three are oral presentations, will be delivered at the International Society on Thrombosis and Haemostasis (ISTH) Virtual Congress being held July 17-21, 2021. Specific details on uniQure’s presentations at ISTH include:Title: Five Year Data Confirms Stable FIX Expression and Sustained Reductions in Bleeding and Factor IX Use Following AMT-060 Gene Therapy in Adults with Severe or Moderate-Severe Hemophilia B (Abstract OC 26.3)Oral Session Title: Hemostatic Agents and Hemostatic EfficacyDate and Time: Monday, July 19, 11:00 – 12:00 p.m. EDTTitle: Clinical...

Mont-Saint-Guibert, Belgium – July 2, 2021, 2:40pm CET / 8:40am ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced the pricing of its initial public offering in the United States (the “Offering”) of 2,835,000 ordinary shares at a price to the public of US$ 30 per share for total gross proceeds of US$ 85.1 million before deducting underwriting discounts and commissions and estimated offering expenses. In addition, Nyxoah has granted the underwriters a 30-day option to purchase up to an additional 425,250 ordinary shares at the initial public offering price less underwriting discounts and commissions, to cover over-allotments, if any. The closing...

Sponsorship Opportunity for PsyTech Summit provides robust environment for awareness alongside some of the biggest names in the psychedelic industry MIAMI, July 02, 2021 (GLOBE NEWSWIRE) — Ehave, Inc., (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics for the psychedelic and mental health sectors, announced today it will be one of four sponsors at PsyTech, an upcoming complimentary Psychedelic Industry summit taking place virtually on July 19-20 for investors and interested individuals. The third annual PsyTech Summit will cover the most heated topics in the psychedelic sector today, like ketamine-assisted therapy, microdosing, promising new innovations in developmental phases, and much more. “Sponsoring the PsyTech Summit is a great opportunity for Ehave and its shareholders as we roll out our KetaDASH platform...

Virtual Conference boasts some of the biggest names in the psychedelic industry MIAMI, July 02, 2021 (GLOBE NEWSWIRE) — Mycotopia Therapies, Inc., (OTC Pink: TPIA) (the “Company”) announced today an upcoming complimentary Psychedelic Industry summit will take place virtually on July 19-20 for investors and interested individuals. The third annual Psytech Summit, where research and industry meet, is produced by PsyTech Inc., a leading source of education, clinical care and clinical tools for the fast-growing psychedelic medical sector. The summit will be a spirited, global discussion focused on today’s most impactful psychedelic therapies, most promising research, and their burgeoning commercial climate through a variety of panels, breakout sessions, and Q&A opportunities with experts. This year’s summit will feature two levels...

Integrity Health Corporation CEO Nelson Grist Announces Company’s New Mission PHOENIX, AZ, July 02, 2021 (GLOBE NEWSWIRE) — via NewMediaWire – Integrity Health Corporation (OTC Pink: FTEG) CEO Nelson Grist is pleased to announce that the Company (www.integrityhealthcorp.com) has a new Mission as a Health Care Company, not just a developer and seller of CBD products. Nelson Grist, CEO of Integrity Health Corporation, said, “The Company’s mission is to: Disrupt the normalcy of traditional Western medicine by making patients more aware they can achieve a healthier, pain-free, longer life through the highest quality products and services designed and dispensed by Integrity Health professionals!” The next step for Integrity Health is to finalize the acquisition of the MedSpa Point Lumineux in Sarasota, Florida from Medical Aesthetics...

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, July 02, 2021 (GLOBE NEWSWIRE) — FIREWEED ZINC LTD. (“Fireweed” or the “Company”) (TSXV: FWZ) is pleased to announce closing of its non-brokered private placement (the “Financing”) announced June 14, 2021 for gross proceeds of CAD$4,503,427 consisting of 5,003,808 flow-through common shares of the Company (“Flow-Through Shares”) at a price of CAD$0.90 per share. The Financing was over-subscribed due to increased demand. The proceeds from the Financing will be used for exploration and development of the Company’s Macmillan Pass Project in Yukon, Canada. Specifically, the Company will incur Canadian Exploration Expenses (“CEE”), which will qualify as “flow-through mining expenditures” under the Income Tax...

SCOTTSDALE, Ariz., July 02, 2021 (GLOBE NEWSWIRE) — AMMO, Inc. (Nasdaq: POWW) (“AMMO” or the “Company”), a premier American ammunition and munition components manufacturer and technology leader, is pleased to provide a link to the transcript and summary excerpts of the Q&A session from the Company’s Fiscal 2021 Earnings call held on June 29, 2021. Replay: https://spaces.hightail.com/receive/hFa3FRFAvO Fiscal 2022 is positioned to be transformative in AMMO’s opinion, with revenue and earnings per share increasing significantly as the Company continues to deploy resources to solidify and enhance 2021’s trajectory through this Fiscal Year. EXCERPTSQ&A session: Matthew Koranda Got it. Okay. Maybe one more from me, and then I’ll turn it over to take turns here. But just in terms of GunBroker, now that it’s been...